Literature DB >> 21967893

Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.

Christoph M Hammers1, Katja Bieber, Kathrin Kalies, David Banczyk, Christoph T Ellebrecht, Saleh M Ibrahim, Detlef Zillikens, Ralf J Ludwig, Jürgen Westermann.   

Abstract

The environment encountered in secondary lymphoid organs (e.g., lymph nodes) influences the outcome of immune responses. Immunization of mice with type VII collagen, an adhesion protein expressed at the cutaneous basement membrane, induces experimental epidermolysis bullosa acquisita (EBA). In this model, clinical disease is associated with the H2s haplotype of the MHC found in SJL/J mice. Most other strains (e.g., BALB/c, C57BL/6, NZM2410/J) are resistant to clinical disease, despite autoantibody production. Comparison of autoantibody response in EBA-resistant and -susceptible mice showed an IgG2-dominated response in the latter. We hypothesized that EBA susceptibility is due to specific cytokine gene expression in draining lymph nodes (dLN). To challenge this hypothesis, EBA-susceptible (SJL/J) and -resistant (BALB/c, C57BL/6) mice were immunized with type VII collagen, followed by analysis of clinical phenotype, subclasses of circulating and tissue-bound autoantibodies, complement activation, and cytokine gene expression in dLN. Disease manifestation was associated with induction of complement-fixing autoantibodies, confirming previous observations. Furthermore, however, IFN-γ/IL-4 ratio in dLN of EBA-susceptible mice was significantly increased compared with EBA-resistant strains, suggesting a Th1 polarization. Immunization of H2s-congenic C57BL/6 mice (B6.SJL-H2s) led to Th1 polarization in dLN and clinical disease. In addition to their cytokine milieu, EBA-susceptible and -resistant mice also differed regarding the expression of FcγR on peripheral leukocytes, in which a higher FcγRIV expression in SJL/J and B6.SJL-H2s mice, compared with C57BL/6, was associated with skin lesions. In summary, blistering in experimental EBA is regulated by both adaptive (divergent class switch recombination due to polarized cytokine expression) and innate (FcγR expression) immune mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21967893     DOI: 10.4049/jimmunol.1100796

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita.

Authors:  Misa Hirose; Benjamin Tiburzy; Norito Ishii; Elena Pipi; Sabina Wende; Ellen Rentz; Falk Nimmerjahn; Detlef Zillikens; Rudolf A Manz; Ralf J Ludwig; Michael Kasperkiewicz
Journal:  J Invest Dermatol       Date:  2014-10-20       Impact factor: 8.551

2.  Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

Authors:  Misa Hirose; Anika Kasprick; Foteini Beltsiou; Katharina Dieckhoff Schulze; Franziska Sophine Schulze; Unni Kjsrl Samavedam; Jennifer E Hundt; Hendri H Pas; Marcel F Jonkman; Enno Schmidt; Kathrin Kalies; Detlef Zillikens; Ralf J Ludwig; Katja Bieber
Journal:  Mol Med       Date:  2016-12-20       Impact factor: 6.354

3.  Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita.

Authors:  Ralf J Ludwig
Journal:  ISRN Dermatol       Date:  2013-07-15

4.  Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice.

Authors:  Sarah Schönig; Andreas Recke; Misa Hirose; Ralf J Ludwig; Karsten Seeger
Journal:  Orphanet J Rare Dis       Date:  2013-06-26       Impact factor: 4.123

5.  T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.

Authors:  Katja Bieber; Mareike Witte; Shijie Sun; Jennifer E Hundt; Kathrin Kalies; Sören Dräger; Anika Kasprick; Trix Twelkmeyer; Rudolf A Manz; Peter König; Jörg Köhl; Detlef Zillikens; Ralf J Ludwig
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

6.  Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.

Authors:  Christian M Karsten; Tina Beckmann; Maike M Holtsche; Jenny Tillmann; Sabrina Tofern; Franziska S Schulze; Eva Nina Heppe; Ralf J Ludwig; Detlef Zillikens; Inke R König; Jörg Köhl; Enno Schmidt
Journal:  Front Immunol       Date:  2018-03-15       Impact factor: 7.561

7.  Blister-inducing antibodies target multiple epitopes on collagen VII in mice.

Authors:  Kinga Csorba; Mircea Teodor Chiriac; Florina Florea; Miruna Georgiana Ghinia; Emilia Licarete; Andreea Rados; Alexandra Sas; Vlad Vuta; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2014-08-05       Impact factor: 5.310

8.  Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.

Authors:  Gina-Maria Lilienthal; Johann Rahmöller; Janina Petry; Yannic C Bartsch; Alexei Leliavski; Marc Ehlers
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

Review 9.  Epidermolysis Bullosa Acquisita: The 2019 Update.

Authors:  Hiroshi Koga; Catherine Prost-Squarcioni; Hiroaki Iwata; Marcel F Jonkman; Ralf J Ludwig; Katja Bieber
Journal:  Front Med (Lausanne)       Date:  2019-01-10

10.  Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice.

Authors:  Anika Kasprick; Maxi Hofrichter; Bryan Smith; Penelope Ward; Katja Bieber; Anthony Shock; Ralf J Ludwig; Enno Schmidt
Journal:  Br J Pharmacol       Date:  2020-03-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.